You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Litigation Details for XMTT, Inc. v. Intel Corporation (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

XMTT, Inc. v. Intel Corporation (D. Del. 2018)

Small Molecule Drugs cited in XMTT, Inc. v. Intel Corporation
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for XMTT, Inc. v. Intel Corporation (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-05-12 117 Opinion - Memorandum Opinion modules.” (’388 patent, 7:1-7; ’879 patent, 7:10-16). “[A]s a general rule claims of a patent are not limited…-19, 15:3-4, 20-23; ’879 patent, col. 2:48-50, 3:25-26, 9:32-33, 52-53, 11:22-23). For example, claim…terms in U.S. Patent Nos. 7,707,388 (“the ’388 patent”) and 8,145,879 (“the ’879 patent”). The Court … Wellcome, Inc. v. Andrx Pharmaceuticals, Inc., 344 F.3d 1226, 1233 (Fed. Cir. 2003). I therefore…infringement of the ’388 and ’879 patents. (D.I. 1). The asserted patents are directed to a “computer memory External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.